|
News
WHO Good Governance for Medicines meeting, Geneva,
Switzerland 5–8 April 2011
A technical group meeting on the WHO Good
Governance for Medicines (GGM) programme was held
in Geneva, Switzerland from 5 to 8 April 2011. The objective of the
meeting was to solicit the input of a group of technical experts in
ongoing efforts to adapt WHO technical assistance in this area to
country needs. Participants included officials from national
medicines authorities who have been involved with the GGM programme
and have an in‐depth knowledge of GGM concepts, documents and
methodology.
The pharmaceutical sector, with a US$ 750 billion global market
value, is vulnerable to fraud and is an obvious target for
corruption. Thus, coordination between various parties involved in
the GGM programme is crucial in ensuring that pharmaceutical
spending is not misappropriated and that essential medicines reach
people – not the black market.
The WHO GGM programme is implemented through a
3-phase model process, starting with a national transparency
assessment and followed by the development and implementation of a
national programme for promoting good governance. This model process
provides countries with a flexible road map to implement the
national GGM programme. It is action-oriented, concrete and
measurable. Ultimately, this process will also assist in
institutionalizing the GGM programme in government structures. The
GGM technical package includes the assessment instrument (phase I),
the model GGM framework (phase II) and the implementation guide
(phase III - under development).
Participants reviewed the GGM model framework,
planned for the GGM impact monitoring and external evaluation,
explored the content of a policy document based on GGM country case
studies and transparency monitoring report and discussed the GGM
global plan of action for 2011.Three officials from the Eastern
Mediterranean Region participated in this event.
Future steps include the finalization of an
impact monitoring framework, publishing the revised WHO GGM model
Framework, conducting a writing workshop with GGM country
representatives on the GGM policy brief, publishing a revised
transparency monitoring report, initiating discussions on a
technical guide for promotion of moral leadership and conducting a
global meeting for GGM phase III countries later in 2011.
For more information on the GGM programme visit:
http://www.who.int/medicines/ggm
|
